HAS vs ZYME · P/E 25, rev $4.75B vs rev $76.3M
Hasbro Inc (HAS) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Hasbro Inc (HAS) is a leisure company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
HAS currently screens at market cap $10.75B and trailing P/E 25.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the HAS and ZYME stock pages for the full models.
Not investment advice.